Jichuan Pharmaceutical Co., Ltd. (600566.SH) released its first half-year performance, with a net profit attributable to shareholders of 724 million yuan, a year-on-year decrease of 45.87%.

The Zhitong Financial APP reported that Jichuan Pharmaceutical (600566.SH) has released its 2025 interim report. During the reporting period, the company achieved operating income of 2.749 billion yuan, a year-on-year decrease of 31.87%. Net profit attributable to shareholders of the listed company was 724 million yuan, a year-on-year decrease of 45.87%. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 621 million yuan, a year-on-year decrease of 47.43%. Basic earnings per share were 0.78 yuan.